Comparative Evaluation of Antimicrobial Efficacy, Clinical and Radiographic Success of Calcium Hydroxide, Chlorhexidine, and Modified Triple Antibiotic Paste in Different Combination Forms As Intracanal Medicaments Against Enterococcus Faecalis in Primary Teeth

NCT ID: NCT06625645

Last Updated: 2024-10-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-01

Study Completion Date

2026-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparing between different intracanal medications with different combination forms of Modified Triple Antibiotic Paste, Calcium Hydroxide and Chlorehexidine, regarding antimicrobial efficacy through bacterial reduction count of enterococcus Faecalis and regarding clinical and radiographic success in non vital primary teeth necessitating pulpectomy with follow up time 1 year.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Full medical and dental history will be obtained from the parents of the patients participating in this study.
2. A thorough clinical and radiographic examination of the tooth to be treated will be done.
3. The tooth will be anaesthetized using the inferior alveolar nerve block technique for lower molars and infiltration for upper molars
4. Before isolation, antisepsis of the oral cavity will be performed by rinsing for 1 min with 10 mL chlorhexidine gluconate mouth-wash 0.2 %.
5. The tooth will be properly isolated using rubber dam.
6. Access cavity will be performed using a round bur.
7. The root canals will be irrigated with 1 ml sterile saline solution.
8. Patency of the root canal will be obtained using stainless steel hand k- files size #15
9. Working length will be determined using apex locator
10. The first microbial samples (S1) will be collected to assess bacterial count of the root canals using 1 sterile paper point size 20, which will be inserted into the widest root canal for 1 min with pumping movements (McGurkin-Smith et al., 2005)
11. It will be placed inside sterile tubes containing a reduced transport medium of thioglycolate.
12. The canals will be thoroughly irrigated using 3ml syringe of 1.25% Sodium hypochlorite. A side-vented needle will be used to control the possibility of irrigant apical extrusion.
13. Mechanical preparation will be performed with rotary system for all the cases.
14. Irrigation with saline solution will be used to neutralize all the previously used solutions.
15. Then, a second microbial samples (S2) representing the antibacterial effect of the mechanical preparation will be obtained with the same procedure as the first sample (S1).
16. According to the randomization sequence, patients will be assigned to one of 4 groups:

1- A mix of modified triple Antibiotic Paste (M-TAP) and normal saline (experimental).

2- A mix of Ca(OH)2 and 2% CHX gluconate solution(experimental). 3- A mix of M-TAP and 2% CHX gluconate solution(experimental). 4- A mix of Ca(OH)2 and normal saline (control) 17) The canals will be dried and filled with intracanal medication plugged into the canal by using a plugger.

18\) At the end of the first visit a piece of sterile cotton will be placed in the pulp chamber.

19\) All teeth will be dressed with intermediate restorative material (IRM) as a temporary filling, in order to ensure proper sealing with no leakage of any oral fluids inside the root canal, which might disturb the action of the intracanal medication.

20\) After 7 days, the temporary restoration will be removed. 21) Disinfection of the operative field will take place as performed previously using the same protocol.

22\) Irrigation of the root canals with 2 mL of saline to flush out the medicaments and the third bacteriological sample (S3) will be taken out.

23\) Later, canals will be filled with Metapex (Metabiomed, Korea), followed by the placement of stainless-steel crowns (3M ESPE).

24\) The samples will be placed in sterile vials with thioglycolate (transport medium). The vials will be sealed tightly to avoid contamination and labeled. The labeled vials will be kept in a freezer and will be sent to the laboratory within 1 hour of collection, and samples will be assessed for total E. faecalis count (Qamar et al., 2023).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Apical Periodontitis Necrotic Primary Molars Periapical Pathosis of Primary Molars

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Calcium Hydroxide mixed with saline as control intracanal medication

using calcium hydroxide with saline as control intracanal medication for necrotic primary molars

Group Type ACTIVE_COMPARATOR

calcium hydroxide mixed with saline as intracanal medication

Intervention Type COMBINATION_PRODUCT

calcium hydroxide mixed with saline as intracanal medication for necrotic primary molars

different types and combinations of intracanal medications for necrotic primary molars

Group Type EXPERIMENTAL

Modified triple antibiotic paste (TAP) mixed with chlorehexidine

Intervention Type COMBINATION_PRODUCT

M-TAP with CHX 2%

Modified Triple Antibiotic Paste mixed with saline

Intervention Type COMBINATION_PRODUCT

M-TAP mixed with saline

Calcium Hydroxide mixed with chlorohexidine Intracanal medication

Intervention Type COMBINATION_PRODUCT

calcium hydroxide powder mixed with CHX 2% solution as intracanal medication

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Modified triple antibiotic paste (TAP) mixed with chlorehexidine

M-TAP with CHX 2%

Intervention Type COMBINATION_PRODUCT

Modified Triple Antibiotic Paste mixed with saline

M-TAP mixed with saline

Intervention Type COMBINATION_PRODUCT

Calcium Hydroxide mixed with chlorohexidine Intracanal medication

calcium hydroxide powder mixed with CHX 2% solution as intracanal medication

Intervention Type COMBINATION_PRODUCT

calcium hydroxide mixed with saline as intracanal medication

calcium hydroxide mixed with saline as intracanal medication for necrotic primary molars

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

• Primary molars necessitating pulpectomy diagnosed with deep dental caries with pulp necrosis, apical periodontitis and periapical pathosis or both.

* Non-Vital pulps.
* Negative response to hot or cold pulp tester (ethyl chloride spray ).
* Decayed tooth with spontaneous unprovoked long dull aching pain showing signs of necrosis of the pulp

Exclusion Criteria

* Medically compromised and uncooperative children
* Tooth indicated for extraction
* Mobile teeth (Miller's Grade 2 or more)
* teeth with more than two-thirds of root resorption
* previous endodontic treatment
Minimum Eligible Age

4 Years

Maximum Eligible Age

8 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mahy Abdel Raouf Aly Kamar

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mahy Abdel Raouf Aly Kamar

Principle investigator

Responsibility Role SPONSOR_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mahy kamar Mahy A.Raouf Kamar, Assistant Lecturer

Role: CONTACT

01550831173

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

main investigator

Identifier Type: REGISTRY

Identifier Source: secondary_id

14422023573623

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.